Literature DB >> 33651407

In vivo evaluation of angulated needle-guide template for MRI-guided transperineal prostate biopsy.

Pedro Moreira1, John Grimble2, Nicusor Iftimia2, Camden P Bay1, Kemal Tuncali1, Jesung Park2, Junichi Tokuda1.   

Abstract

PURPOSE: Magnetic resonance imaging (MRI)-guided transperineal prostate biopsy has been practiced since the early 2000s. The technique often suffers from targeting error due to deviation of the needle as a result of physical interaction between the needle and inhomogeneous tissues. Existing needle guide devices, such as a grid template, do not allow choosing an alternative insertion path to mitigate the deviation because of their limited degree-of-freedom (DoF). This study evaluates how an angulated needle insertion path can reduce needle deviation and improve needle placement accuracy.
METHODS: We extended a robotic needle-guidance device (Smart Template) for in-bore MRI-guided transperineal prostate biopsy. The new Smart Template has a 4-DoF needle-guiding mechanism allowing a translational range of motion of 65 and 58 mm along the vertical and horizontal axis, and a needle rotational motion around the vertical and horizontal axis ± 30 ∘ and a vertical rotational range of - 30 ∘ , + 10 ∘ , respectively. We defined a path planning strategy, which chooses between straight and angulated insertion paths depending on the anatomical structures on the potential insertion path. We performed (a) a set of experiments to evaluate the device positioning accuracy outside the MR-bore, and (b) an in vivo experiment to evaluate the improvement of targeting accuracy combining straight and angulated insertions in animal models (swine, n = 3 ).
RESULTS: We analyzed 46 in vivo insertions using either straight or angulated insertions paths. The experiment showed that the proposed strategy of selecting straight or angulated insertions based on the subject's anatomy outperformed the conventional approach of just straight insertions in terms of targeting accuracy (2.4 mm [1.3-3.7] vs 3.9 mm [2.4-5.0] {Median IQR } ); p = 0.041 after the bias correction).
CONCLUSION: The in vivo experiment successfully demonstrated that an angulated needle insertion path could improve needle placement accuracy with a path planning strategy that takes account of the subject-specific anatomical structures.
© 2021 American Association of Physicists in Medicine.

Entities:  

Keywords:  MRI-guided biopsy; medical robotics; needle deviation; prostate; robot-assisted biopsy; targeted biopsy; transperineal biopsy

Mesh:

Year:  2021        PMID: 33651407      PMCID: PMC8141017          DOI: 10.1002/mp.14816

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  22 in total

1.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  3T MR-guided in-bore transperineal prostate biopsy: A comparison of robotic and manual needle-guidance templates.

Authors:  Gaurie Tilak; Kemal Tuncali; Sang-Eun Song; Junichi Tokuda; Olutayo Olubiyi; Fiona Fennessy; Andriy Fedorov; Tobias Penzkofer; Clare Tempany; Nobuhiko Hata
Journal:  J Magn Reson Imaging       Date:  2014-09-27       Impact factor: 4.813

3.  MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions.

Authors:  Stephan Zangos; Andreas Melzer; Katrin Eichler; Cyrus Sadighi; Axel Thalhammer; Boris Bodelle; Renate Wolf; Tatjana Gruber-Rouh; Dirk Proschek; Renate Hammerstingl; Cindy Müller; Martin G Mack; Thomas J Vogl
Journal:  Radiology       Date:  2011-03-01       Impact factor: 11.105

4.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

5.  MR Safe Robot, FDA Clearance, Safety and Feasibility Prostate Biopsy Clinical Trial.

Authors:  Dan Stoianovici; Chunwoo Kim; Doru Petrisor; Changhan Jun; Sunghwan Lim; Mark W Ball; Ashley Ross; Katarzyna J Macura; Mohamad Allaf
Journal:  IEEE ASME Trans Mechatron       Date:  2016-10-20       Impact factor: 5.303

6.  Development and Evaluation of an Actuated MRI-Compatible Robotic System for MRI-Guided Prostate Intervention.

Authors:  Axel Krieger; Sang-Eun Song; Nathan B Cho; Iulian Iordachita; Peter Guion; Gabor Fichtinger; Louis L Whitcomb
Journal:  IEEE ASME Trans Mechatron       Date:  2011-10-17       Impact factor: 5.303

7.  ROS-IGTL-Bridge: an open network interface for image-guided therapy using the ROS environment.

Authors:  Tobias Frank; Axel Krieger; Simon Leonard; Niravkumar A Patel; Junichi Tokuda
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-05-31       Impact factor: 2.924

8.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

9.  Evaluation of robot-assisted MRI-guided prostate biopsy: needle path analysis during clinical trials.

Authors:  Pedro Moreira; Niravkumar Patel; Marek Wartenberg; Gang Li; Kemal Tuncali; Tamas Heffter; Everette C Burdette; Iulian Iordachita; Gregory S Fischer; Nobuhiko Hata; Clare M Tempany; Junichi Tokuda
Journal:  Phys Med Biol       Date:  2018-10-16       Impact factor: 3.609

10.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.